Evidence map›Paper›PMID 26865001›Full record

ReviewMolecular nutrition & food research2016

Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma.

Feng Liu-Smith, Frank L Meyskens

Open access · greenAbstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 147 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Methoxylated Chrysin and Quercetin as Potent Stimulators of Melanogenesis.International journal of molecular sciences · 2025
    Article
  11. A Phytobiotic Supersupplement FromAquaculture nutrition · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Identification of active compounds inFrontiers in pharmacology · 2024
    Article
  18. Frontiers in pharmacology · 2024
    Article
  19. Article
  20. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Feng Liu-SmithDepartment of Epidemiology, UC Irvine, Irvine, CA, USA.
Frank L MeyskensDepartment of Epidemiology, UC Irvine, Irvine, CA, USA.
UC Irvine Health · USUniversity of California, Irvine · US

Funding

Melanoma Risk: Interactions between UV Radiation and NADPH Oxidase Gene FamilyK07CA160756 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LIU-SMITH, FENG · 2013 to 2017
$647k
NCI NIH HHS K07 CA160756
6 · The paper itself

Abstract

Flavonoids are becoming popular nutraceuticals. Different flavonoids show similar or distinct biological effects on different tissues or cell types, which may limit or define their usefulness in cancer prevention and/or treatment application. This review focuses on a few selected flavonoids and discusses their functions in normal and transformed pigment cells, including cyanidin, apigenin, genistein, fisetin, EGCG, luteolin, baicalein, quercetin and kaempferol. Flavonoids exhibit melanogenic or anti-melanogenic effects mainly via transcriptional factor MiTF and/or the melanogenesis enzymes tyrosinase, DCT or TYRP-1. To identify a direct target has been a challenge as most studies were not able to discriminate whether the effect(s) of the flavonoid were from direct targeting or represented indirect effects. Flavonoids exhibit an anti-melanoma effect via inhibiting cell proliferation and invasion and inducing apoptosis. The mechanisms are also multi-fold, via ROS-scavenging, immune-modulation, cell cycle regulation and epigenetic modification including DNA methylation and histone deacetylation. In summary, although many flavonoid compounds are extremely promising nutraceuticals, their detailed molecular mechanism and their multi-target (simultaneously targeting multiple molecules) nature warrant further investigation before advancement to translational studies or clinical trials.

Indexed as

AnimalsAnthocyaninsAntioxidantsApoptosisCell Line, TumorCell ProliferationDicarboxylic Acid TransportersDNA MethylationEpigenesis, GeneticFlavonoidsHumansMelaninsMelanomaMonophenol MonooxygenaseNeoplasm MetastasisReactive Oxygen SpeciesAnthocyaninsAntioxidantsDicarboxylic Acid TransportersFlavonoidsMelaninsMonophenol MonooxygenaseReactive Oxygen SpeciesFlavonoidsLuteolinMelanogenesisMelanomaPrevention

Identifiers

PMID26865001
PMCPMC4900912
OpenAlexW2287529952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.